Literature DB >> 12719374

Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females.

Ole P Kristiansen1, Runa L Nolsøe, Lykke Larsen, Anette M P Gjesing, Jesper Johannesen, Zenia M Larsen, Anne E Lykkesfeldt, Allan E Karlsen, Flemming Pociot, Thomas Mandrup-Poulsen.   

Abstract

The type 1 diabetes mellitus (T1DM) candidate gene SNP IL6-174G/C was genotyped in 253 Danish T1DM families (1129 individuals). TDT analysis demonstrated linkage in the presence of association between the IL6-174C allele and T1DM in the 416 T1DM offspring, P(tdt)=0.04. Gender conditioned TDT analyses revealed that linkage and association with T1DM were present in females exclusively; P(tdt)=6.5 x 10(-4) and P(tdt)=2.4 x 10(-4), respectively. Random transmission of the IL6-174C/G alleles was found in T1DM males, non-T1DM males and non-T1DM females; all P(tdt)>/=0.37. Heterogeneity analyses (T1DM versus non-T1DM females) excluded preferential meiotic segregation in females, P=4.6 x 10(-3), and demonstrated differences in the transmission patterns between female and male T1DM offspring, P=5.1 x 10(-3). The IL6-174 CC genotype was associated with younger age at onset of T1DM in females (P=0.002). The impact of 17beta-estradiol (E(2)) on the IL6-174G/C variants was investigated by reporter studies. The PMA stimulated activity of the T1DM risk IL6-174C variant exceeded that of the T1DM protective IL6-174G variant by approximately 70% in the absence of E(2) (P(c)=0.004), but not with E(2) present (P(c)=0.12). The PMA stimulated activity of the IL6-174G variant was repressed without E(2) present, but was derepressed by addition of E(2), P(c)=0.024. In contrast, the PMA stimulated IL6-174C activity was unaffected by E(2) as were the constitutive activities of the IL6-174G/C variants. In conclusion, higher IL6 promoter activity may confer risk to T1DM in very young females. This excess risk is negated with increasing age, possibly by the increasing E(2) levels in puberty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719374     DOI: 10.1093/hmg/ddg132

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

2.  IL-6 polymorphism in non-small cell lung cancer: a prognostic value?

Authors:  Mónica Gomes; Ana Coelho; António Araújo; Andreia Azevedo; Ana Luísa Teixeira; Raquel Catarino; Rui Medeiros
Journal:  Tumour Biol       Date:  2015-01-09

3.  Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.

Authors:  Esmaeil Moazemi Godarzi; Eskandar Kamali Sarvestani; Elham Aflaki; Zahra Amirghofran
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

4.  Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.

Authors:  M San Luciano; L Ozelius; R B Lipton; D Raymond; S B Bressman; R Saunders-Pullman
Journal:  Neurosci Lett       Date:  2011-12-01       Impact factor: 3.046

5.  Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Nathaniel Rothman; Yawei Zhang; Sophia S Wang; Min Shen; Sonja I Berndt; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

6.  Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects.

Authors:  J A Lamb; G Barnby; E Bonora; N Sykes; E Bacchelli; F Blasi; E Maestrini; J Broxholme; J Tzenova; D Weeks; A J Bailey; A P Monaco
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

7.  Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan.

Authors:  Nain-Feng Chu; Fu-Hung Lin; Hsien-Chuan Chin; Ye-Jen Hong
Journal:  Lipids Health Dis       Date:  2011-08-12       Impact factor: 3.876

8.  Tolerogenic function of Blimp-1 in dendritic cells.

Authors:  Sun Jung Kim; Yong Rui Zou; Jordan Goldstein; Boris Reizis; Betty Diamond
Journal:  J Exp Med       Date:  2011-09-26       Impact factor: 14.307

9.  Effect of interleukin-6 polymorphism on risk of preterm birth within population strata: a meta-analysis.

Authors:  Wilfred Wu; Erin A S Clark; Gregory J Stoddard; W Scott Watkins; M Sean Esplin; Tracy A Manuck; Jinchuan Xing; Michael W Varner; Lynn B Jorde
Journal:  BMC Genet       Date:  2013-04-25       Impact factor: 2.797

10.  Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.

Authors:  Jun Yan; Jia Liu; Clement Yihao Lin; Peter A Csurhes; Michael P Pender; Pamela A McCombe; Judith M Greer
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.